Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer

Similar documents
Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

PSA Screening for Prostate Cancer Information for Care Providers

Prostate Cancer Screening. Dr. J. McCracken, Urologist

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

Focal therapy for prostate cancer: seriously or seriously? Disclosures

Prostate cancer. Christopher Eden. The Royal Surrey County Hospital, Guildford & The Hampshire Clinic, Old Basing.

Historical Basis for Concern

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls

Advances in Diagnostic and Molecular Testing in Prostate Cancer

Prostate Cancer. Treatments as unique as you are

Clinical Trials and Radiation Treatment. Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto

Prostatectomy, pelvic lymphadenect. Med age 63 years Mean followup 53 months No other cancer related therapy before recurrence. Negative.

Early Prostate Cancer: Questions and Answers. Key Points

Robert Bristow MD PhD FRCPC

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Role of MRI in the Diagnosis of Prostate Cancer, A Proposal

Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward

Saturation Biopsy for Diagnosis and Staging of Prostate Cancer. Original Policy Date

PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.

The 4Kscore blood test for risk of aggressive prostate cancer

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

Prostate Cancer. Patient Information

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

PSA screening: Controversies and Guidelines

Prostate Cancer. What is prostate cancer?

Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?

The 4Kscore blood test for risk of aggressive prostate cancer

Us TOO University Presents: Understanding Diagnostic Testing

Questions to ask my doctor: About prostate cancer

For further information on screening and early detection of prostate cancer, see the Section entitled Screening for Prostate Cancer.

FAQ About Prostate Cancer Treatment and SpaceOAR System

The PSA Controversy: Defining It, Discussing It, and Coping With It

PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology

HEALTH NEWS PROSTATE CANCER THE PROSTATE

CYBERKNIFE RADIOSURGERY FOR EARLY PROSTATE CANCER Rationale and Results. Alan Katz MD JD Flushing, NY USA

Magnetic Resonance Imaging Targeted Biopsy of the Prostate

Questions to Ask My Doctor About Prostate Cancer

Advice to patients about the PSA (prostate-specific antigen) blood test: frequently-asked questions

TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER

A New Biomarker in Prostate Cancer Care: Oncotype Dx. David M Albala, MD Chief of Urology Crouse Hospital Syracuse, NY

Bard: Prostate Cancer Treatment. Bard: Pelvic Organ Prolapse. Prostate Cancer. An overview of. Treatment. Prolapse. Information and Answers

Newly Diagnosed Prostate Cancer: Understanding Your Risk

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Corporate Medical Policy Saturation Biopsy for Diagnosis and Staging of Prostate Cancer

Prostate Cancer Treatment

Choline PET/CT in Prostate Cancer Imaging

Cancer research in the Midland Region the prostate and bowel cancer projects

A PATIENT S GUIDE TO ABLATION THERAPY

DIAGNOSIS OF PROSTATE CANCER

Focal Therapy for Localized Prostate Cancer: A Phase I/II Trial

A Woman s Guide to Prostate Cancer Treatment

7. Prostate cancer in PSA relapse

Prostate Cancer Action Plan: Choosing the treatment that s right for you

An Introduction to PROSTATE CANCER

SRO Tutorial: Prostate Cancer Treatment Options

High Intensity Focused Ultrasound for Prostate Cancer

Prostate Cancer 2014

Prostate Cancer Screening. A Decision Guide

PATIENT GUIDE. Localized Prostate Cancer

Current and Future Trends in Proton Treatment of Prostate Cancer

Novel Surgery for Inoperable Brain Tumors. A Patient Guide to NeuroBlate

In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer

Focal Therapy for Localised Prostate Cancer

Screening for Prostate Cancer

Prostate Cancer Screening: Are We There Yet? March 2010 Andrew M.D. Wolf, MD University of Virginia School of Medicine

Treating Prostate Cancer

Review of Focal Therapy for Localized Prostate Cancer

Prostate Cancer & Its Treatment

2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER

Prostate Cancer Screening. A Decision Guide for African Americans

Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

SIOG Guidelines Update 2014 Prostate Cancer. Dr Helen Boyle Centre Léon Bérard SIOG meeting 25 October 2014,Lisbon

Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion Device

Prostate Cancer In-Depth

PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?

1. What is the prostate-specific antigen (PSA) test?

Radiation Therapy for Prostate Cancer: Treatment options and future directions

Transcription:

Real Time MRI guided Focal Laser Ablation Therapy for Prostate Cancer A/Prof Celi Varol and Dr Orit Raz Uro-Oncologist Nepean and Macquarie Hospital Trial at Macquarie University Hospital Ethics board and TGA approved

Prostate Cancer in 2015 Treatment of PCa saves lives Side effects of treatment can outweigh the benefits Better understanding of NNT

Prostate Cancer 2015 PCa screening = increases the incidence of Indolent disease Less aggressive approach / organ preservation Active surveillance

Active Surveillance Low volume disease ->Disease Progression ->Anxiety >>>>> Focal Therapy <<<<< ->Radical Rx

In 2015 Focal Therapy Patient selection!!!

Ideal Focal Therapy 1.Clearly identify and localize tumour - Targeting 2.Navigate ablation energy to target 3.Completely destroy ONLY target 4.Real time monitoring of tumour destruction 5.Have NO side effects 6.Be prepared and able to repeat if necessary 7.Eligible for more radical treatment in the future.

Clearly identify and localize tumour - Targeting 1. mpmri of the prostate 2. MRI guided biopsy

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer Thompson James et al. BJU international 2013,

In recent years, the availability of 3 Tesla magnets has led to increased use of MRI in the detection of PCa. PIRADS The combination of anatomical (T2-weighted) MRI with functional MRI parameters (DW, DCE or spectroscopy) will detect > 90% of significant Pca (2013). MRI is less reliable at detecting tumours that are: < 0.5 cc low grade, Gleason score<7 transitional zone

Navigate to Tumour Combined T2W and DWI MRI for tumor localization Prostate Tumour

Real time FLT In the bore of the MR scanner Under general anesthesia Supine or Prone Brachy-template / TR probe

Transrectal Transperineal

Localisation of Tumour with laser fiber on real time MRI

Laser Fiber position

Dr. John Trachtenberg University of Toronto, Toronto, CA January 26, 2010 Visualase System eatment temperature map Irreversible damage estim

Tissue temperature map measured by MR thermometry - during laser ablation Calculated actual damage

Ideal Focal Therapy 1.Clearly identify and localize tumour - Targeting 2.Navigate ablation energy to target 3.Completely destroy ONLY target 4.Real time monitoring of tumour destruction 5.Have NO side effects 6.Be prepared and able to repeat if necessary 7.Eligible for more radical treatment in the future.

Prostate Cancer Patient PSA 6.0 ng/ml DRE normal MRI guided biopsy ¾ cores Gleason 3+4=7 20-50% of cores Random biopsy x12 normal IPSS and IIEF normal

MRI guided Bx Gleas 7 Pca PSA 6ng/ml 63yo

6 months post FLT MRI guided Bx

Fibrosis No Prostate Cancer

60 years old PSA 5.8 mpmri : 0.4 cc, PIRADS 3/5 Left posterior lateral TP biopsy matched Gleason s (3+4), in 1/24 cores

FLT Nov 2014

Post FLT contrast enhanced MRI

6 months post FLT mpmri new lesion

MRI GBx from post FLT lesion Area of fibrosis and chronic inflamation

MRI GB from new lesion right Apex: Gleason s score (4+3)

Robotic radical Prostatectomy Uneventful RALRP Bilateral nerve spare pt2 Gleason s (4+3), 60% HG 0.2 cc tumor volume No residual tumor at treated area

Results February 2014 15 patients Average age 59.6y Pre treatment PSA 4.5 ng/ml (2.4 7.7) lesion size 25mm (5-56)

Complications: 2 Urinary retention 2 Perineal discomfort Patients discharged home within < 2 hours No major complications Preservation of urethra, rectum, and NVBs IPSS and IIEF at 1 month = normal PSA drop @10-20%

CONCLUSION In Selective patients Outpatient procedure No technical issues GA / Sedation More studies should be done, with larger number of patients and long-term follow-up, to confirm the disease and biochemical free survival benefit of this technique.

Who needs radical Rx Vs Surveillance? NNT is 10 20 high grade NNT is 20 30 intermediate grade

1. MRI guided FLT treats PCa 2. Assists in guiding/tailoring who will benefit from Radical Rx